[144] PG&E Corporation SEC Filing
PG&E Corporation (PCG) filed a Form 144 reporting a proposed sale of 7,000 common shares through Charles Schwab & Co., with an aggregate market value of $106,015. The sale is noted for approximately 08/11/2025 on the NYSE.
The shares were acquired on 05/16/2024 via a restricted stock lapse from PG&E as equity compensation. The filing states there were no securities sold in the past three months for the account, and the filer certifies they have no undisclosed material adverse information. The 7,000 shares represent roughly 0.00026% of the 2,675,580,992 shares outstanding.
PG&E Corporation (PCG) ha presentato un Form 144 segnalando la proposta vendita di 7,000 azioni ordinarie tramite Charles Schwab & Co., per un valore complessivo di $106,015. L'operazione 猫 indicata per circa 08/11/2025 sul NYSE.
Le azioni sono state acquisite il 05/16/2024 a seguito della scadenza delle restrizioni sulle azioni da PG&E come retribuzione azionaria. Il deposito dichiara che non sono stati venduti titoli nei tre mesi precedenti per il conto, e il dichiarante certifica di non avere informazioni materiali negative non divulgate. Le 7,000 azioni rappresentano circa il 0.00026% delle 2,675,580,992 azioni in circolazione.
PG&E Corporation (PCG) present贸 un Form 144 informando la propuesta venta de 7,000 acciones ordinarias a trav茅s de Charles Schwab & Co., por un valor total de $106,015. La venta est谩 prevista para aproximadamente 08/11/2025 en la NYSE.
Las acciones fueron adquiridas el 05/16/2024 mediante el vencimiento de restricciones sobre acciones restringidas de PG&E como compensaci贸n en acciones. La presentaci贸n indica que no se vendieron valores en los 煤ltimos tres meses en la cuenta, y el declarante certifica no poseer informaci贸n material adversa no divulgada. Las 7,000 acciones representan aproximadamente el 0.00026% de las 2,675,580,992 acciones en circulaci贸n.
PG&E Corporation (PCG)臧赌 Form 144鞚� 鞝滌稖頃橃棳 Charles Schwab & Co.毳� 韱淀暣 齑� 鞁滌灔臧赌旃� $106,015鞐� 頃措嫻頃橂姅 7,000 氤错喌欤� 毵る弰毳� 鞝滌晥頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 鞚� 瓯半灅電� NYSE鞐� 鞎� 08/11/2025搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 欤检嫕鞚� 05/16/2024鞐� PG&E搿滊秬韯办潣 鞝滍暅欤� 頃挫牅搿涤劀 欤检嫕 氤挫儊 順曧儨搿� 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 瓿勳鞐愳劀 瓿缄卑 3臧滌洈 霃欖晥 毵る弰霅� 歃濌秾鞚� 鞐嗠嫟瓿� 鞝侅嫓霅橃柎 鞛堨溂氅�, 鞝滌稖鞚胳潃 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧赌 鞐嗢潓鞚� 鞚胳頃╇媹雼�. 鞚� 7,000欤茧姅 氚滍枆欤检嫕靾� 2,675,580,992欤检潣 鞎� 0.00026%鞐� 頃措嫻頃╇媹雼�.
PG&E Corporation (PCG) a d茅pos茅 un Form 144 signalant une proposition de vente de 7,000 actions ordinaires via Charles Schwab & Co., pour une valeur marchande globale de $106,015. La vente est indiqu茅e pour environ 08/11/2025 sur le NYSE.
Les actions ont 茅t茅 acquises le 05/16/2024 par l'茅ch茅ance des restrictions sur des actions restreintes de PG&E en tant que r茅mun茅ration en actions. Le d茅p么t indique qu'aucun titre n'a 茅t茅 vendu au cours des trois derniers mois pour le compte, et le d茅clarant certifie ne pas d茅tenir d'informations d茅favorables importantes non divulgu茅es. Les 7,000 actions repr茅sentent environ 0.00026% des 2,675,580,992 actions en circulation.
PG&E Corporation (PCG) hat ein Form 144 eingereicht, in dem ein geplanter Verkauf von 7.000 Stammaktien 眉ber Charles Schwab & Co. mit einem Gesamtmarktwert von $106,015 gemeldet wird. Der Verkauf ist f眉r ca. 08/11/2025 an der NYSE vermerkt.
Die Aktien wurden am 05/16/2024 durch das Ablaufen von beschr盲nkten Aktien von PG&E als 础办迟颈别苍惫别谤驳眉迟耻苍驳 erworben. In der Meldung hei脽t es, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden und der Melder best盲tigt, keine nicht offengelegten, wesentlichen nachteiligen Informationen zu besitzen. Die 7.000 Aktien entsprechen etwa 0.00026% der 2,675,580,992 ausstehenden Aktien.
- None.
- None.
Insights
TL;DR: A routine insider sale of 7,000 shares from equity compensation; size is immaterial relative to outstanding shares.
The filing reports a planned sale of 7,000 shares valued at $106,015, to be executed via Charles Schwab on 08/11/2025. These shares were acquired through a restricted stock lapse on 05/16/2024, indicating they originated from compensation rather than an open-market acquisition. Given the issuer's reported 2,675,580,992 shares outstanding, the position equals about 0.00026% of the float, which is immaterial from a market-impact perspective. The filing also notes no sales in the past three months for this account.
TL;DR: Compliance-focused disclosure of an executive/insider equity-compensation sale; documentation appears routine and complete for Rule 144 purposes.
The notice documents that the securities were acquired by a restricted stock lapse and will be sold under Rule 144, using Charles Schwab as broker. The filer affirms they are not aware of undisclosed material adverse information. The absence of prior sales in the past three months is recorded as "Nothing to Report". From a governance standpoint, the filing satisfies standard disclosure elements required for an insider sale notification.
PG&E Corporation (PCG) ha presentato un Form 144 segnalando la proposta vendita di 7,000 azioni ordinarie tramite Charles Schwab & Co., per un valore complessivo di $106,015. L'operazione 猫 indicata per circa 08/11/2025 sul NYSE.
Le azioni sono state acquisite il 05/16/2024 a seguito della scadenza delle restrizioni sulle azioni da PG&E come retribuzione azionaria. Il deposito dichiara che non sono stati venduti titoli nei tre mesi precedenti per il conto, e il dichiarante certifica di non avere informazioni materiali negative non divulgate. Le 7,000 azioni rappresentano circa il 0.00026% delle 2,675,580,992 azioni in circolazione.
PG&E Corporation (PCG) present贸 un Form 144 informando la propuesta venta de 7,000 acciones ordinarias a trav茅s de Charles Schwab & Co., por un valor total de $106,015. La venta est谩 prevista para aproximadamente 08/11/2025 en la NYSE.
Las acciones fueron adquiridas el 05/16/2024 mediante el vencimiento de restricciones sobre acciones restringidas de PG&E como compensaci贸n en acciones. La presentaci贸n indica que no se vendieron valores en los 煤ltimos tres meses en la cuenta, y el declarante certifica no poseer informaci贸n material adversa no divulgada. Las 7,000 acciones representan aproximadamente el 0.00026% de las 2,675,580,992 acciones en circulaci贸n.
PG&E Corporation (PCG)臧赌 Form 144鞚� 鞝滌稖頃橃棳 Charles Schwab & Co.毳� 韱淀暣 齑� 鞁滌灔臧赌旃� $106,015鞐� 頃措嫻頃橂姅 7,000 氤错喌欤� 毵る弰毳� 鞝滌晥頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 鞚� 瓯半灅電� NYSE鞐� 鞎� 08/11/2025搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 欤检嫕鞚� 05/16/2024鞐� PG&E搿滊秬韯办潣 鞝滍暅欤� 頃挫牅搿涤劀 欤检嫕 氤挫儊 順曧儨搿� 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 瓿勳鞐愳劀 瓿缄卑 3臧滌洈 霃欖晥 毵る弰霅� 歃濌秾鞚� 鞐嗠嫟瓿� 鞝侅嫓霅橃柎 鞛堨溂氅�, 鞝滌稖鞚胳潃 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧赌 鞐嗢潓鞚� 鞚胳頃╇媹雼�. 鞚� 7,000欤茧姅 氚滍枆欤检嫕靾� 2,675,580,992欤检潣 鞎� 0.00026%鞐� 頃措嫻頃╇媹雼�.
PG&E Corporation (PCG) a d茅pos茅 un Form 144 signalant une proposition de vente de 7,000 actions ordinaires via Charles Schwab & Co., pour une valeur marchande globale de $106,015. La vente est indiqu茅e pour environ 08/11/2025 sur le NYSE.
Les actions ont 茅t茅 acquises le 05/16/2024 par l'茅ch茅ance des restrictions sur des actions restreintes de PG&E en tant que r茅mun茅ration en actions. Le d茅p么t indique qu'aucun titre n'a 茅t茅 vendu au cours des trois derniers mois pour le compte, et le d茅clarant certifie ne pas d茅tenir d'informations d茅favorables importantes non divulgu茅es. Les 7,000 actions repr茅sentent environ 0.00026% des 2,675,580,992 actions en circulation.
PG&E Corporation (PCG) hat ein Form 144 eingereicht, in dem ein geplanter Verkauf von 7.000 Stammaktien 眉ber Charles Schwab & Co. mit einem Gesamtmarktwert von $106,015 gemeldet wird. Der Verkauf ist f眉r ca. 08/11/2025 an der NYSE vermerkt.
Die Aktien wurden am 05/16/2024 durch das Ablaufen von beschr盲nkten Aktien von PG&E als 础办迟颈别苍惫别谤驳眉迟耻苍驳 erworben. In der Meldung hei脽t es, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden und der Melder best盲tigt, keine nicht offengelegten, wesentlichen nachteiligen Informationen zu besitzen. Die 7.000 Aktien entsprechen etwa 0.00026% der 2,675,580,992 ausstehenden Aktien.
FAQ
What did PG&E (PCG) report in the Form 144?
How were the 7,000 shares acquired according to the filing?
Does the filing show other sales by this person in the past three months?
What broker and exchange are listed for the proposed sale?
How significant is the sale relative to shares outstanding?
